Streetbeat News

Regulatory

NUWE

Nuwellis, Inc. (NUWE) has announced a 1-for-35 reverse stock split, which will consolidate every 35 shares of its common stock into one share. This move is aimed at regaining compliance with the Nasdaq's minimum bid price requirement.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:46 pm

BHP

BHP Group Ltd (NYSE:BHP) anticipates an increase in carbon emissions for 2024 due to organic growth and lower metal content in extracted ore. Despite this, BHP remains committed to reducing its operational greenhouse gas emissions by 30% from 2020 levels by 2030. The company plans to increase the use of solar power and transition to full-battery electric trucks. BHP also aims to collaborate with steel producers to reduce emissions intensity by 30% by 2030 and is considering ammonia-fueled ships and methane drainage to cut emissions in shipping and coal mining.

Portfolio Pulse from Stjepan Kalinic

June 26, 2024 | 12:40 pm

CBUS

Cibus has expanded its intellectual property coverage by securing additional patents for 10 plant trait and editing families. This strengthens its portfolio in areas such as pod shatter reduction, herbicide tolerances, high fiber wheat, and improved quality alfalfa. The patents cover regions including Europe, Asia, Latin America, Canada, and the U.S.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:40 pm

JAGX

Jaguar Health has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the exchange.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:35 pm

GILD

Gilead Sciences Canada announced that its Phase 3 PURPOSE 1 trial for Lenacapavir showed 100% efficacy in preventing HIV in cisgender women. An independent Data Monitoring Committee recommended stopping the blinded phase and offering open-label Lenacapavir to all participants.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:34 pm

RNXT

The University of Nebraska Medical Center will enroll patients for RenovoRx's Phase III TIGeR-PaC clinical trial, which is focused on treating pancreatic cancer.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:34 pm

RTX

Collins Aerospace, a subsidiary of RTX Corp (NYSE:RTX), is in discussions with NASA to withdraw from its contract to develop new spacesuits for the ISS. This marks a setback for NASA, which has faced issues with its aging spacesuits. Collins' withdrawal could leave future suit development to Axiom Space.

Portfolio Pulse from Vandana Singh

June 26, 2024 | 12:11 pm

VIR

Vir Biotechnology's combination drug for chronic hepatitis delta infection has received FDA clearance and Fast Track designation. The drug, consisting of tobevibart and elebsiran, is currently in Phase 2 trials with results expected in Q4.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:06 pm

EYPT

EyePoint Pharmaceuticals announced significant clinical and regulatory developments for its DURAVYU treatment, including Phase 3 trial designs for wet AMD and positive Phase 2 data. The company will webcast its R&D Day event today.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:06 pm

BCLI

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI) has reached alignment with the FDA on the Chemistry, Manufacturing, and Controls (CMC) aspects of its Phase 3b clinical trial for NurOwn, an investigational therapy for amyotrophic lateral sclerosis (ALS).

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:05 pm